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ABSTRACT
We present a 56-year-old patient suffering from frontotemporal dementia with parkinsonism linked to
chromosome 17 (FTDP-17). The history included a three-generation pedigree and the patient was found
to be a mutation carrier. The diagnosis was hindered by late appearance of the hypokinetic movement
disorder. For clinicians, it is important to consider rare neurodegenerative disease variants in early-onset
familial dementia syndromes with behavioral, cognitive, and motor symptoms.
Key words: frontotemporal dementia, dementia, genetics, Parkinson’s disease
Introduction
Although the general causes and classification of
early-onset (<65 years) dementia do not differ
from old life dementia (Lambert et al., 2014),
familial dementia syndromes, such as monogenetic
Alzheimer‘s disease due to amyloid precursor
protein (APP) and presenelin (PSEN1, PSEN2)
gene mutations, often present as early onset
disease (Kasuga et al., 2015). Regarding familial
tauopathies, the clinician should consider MAPT
(microtubule-associated protein tau) mutations
(Im et al., 2015; Irwin, 2015). These mutations
are associated with frontotemporal dementia with
parkinsonism linked to chromosome 17 (FTDP-
17) (Sperfeld et al., 1999), but for specific MAPT
mutations Alzheimer’s disease-like phenotypes
have been described (Rademakers et al., 2003;
Wszolek et al., 2006; Kasuga et al., 2015). A
genetic overlap between Alzheimer’s disease and
Parkinson’s disease in the MAPT locus has been
reported recently (Desikan et al., 2015). Patients
with MAPT mutations may show highly variable
clinical syndromes including frontotemporal lobar
degeneration with parkinsonism, behavioral variant
of frontotemporal dementia, as well as progressive
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supranuclear palsy- and corticobasal degeneration-
like syndromes (Im et al., 2015; Irwin, 2015).
FTDP-17 is a rare autosomal dominant neuro-
degenerative disease with three core features: (a)
behavioral and personality changes, (b) cognitive
dysfunction, and (c) parkinsonism-like motor
symptoms (Wszolek et al., 2006). Approximately,
40 MAPT mutations have been described (Wszolek
et al., 2006). The parkinsonism often presents
as a parkinson-plus syndrome with poor Dopa-
responsiveness, frequent falls, supranuclear gaze
palsy, and sometimes apraxia or dystonia (Wszolek
et al., 2006). FTDP-17 patients may suffer from
a parkinson-plus predominant disease, but a
dementia predominant phenotype is more common
(Reed et al., 2001).
Case report
In 2013, a 56-year-old Caucasian woman presented
to our memory clinic with an approximately three-
year history of progressive memory impairment,
orientation deficits, and subtle behavioral changes.
Her husband told us about a new preference for
chintzy things, which he considered inconsistent
with her rational character before symptom onset.
He also remembered an episode of compulsive
behavior when his wife repeatedly checked their
locked apartment entrance door. Finally, he
reported a tendency to fall when riding her bicycle.
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Our patient had a positive family history of early
onset dementia. Her mother with severe dementia
died at the age of 56. Due to a detailed psychiatric
evaluation her mother had to undergo because
of her incapacity to work, we learned about her
cognitive, dysexecutive, and behavioral symptoms
that were similar to our patient’s. Her maternal
grandfather committed suicide at the age of 54
being affected by severe cognitive deficits despite
his young age.
In the clinical and neurological examination,
we initially observed increased right-lateralized
tone and vivid reflexes, accompanied by a general
psychomotor slowing, depressed mood, and a
tendency to dissimulate cognitive deficits. Brain
magnetic resonance imaging (MRI) showed no
abnormalities. Cerebrospinal fluid (CSF) analysis
did not reveal amyloid or tau pathology and
fluodesoxyglucose positron emission tomography
(FDG-PET) showed a normal glucose metabolism
except for subtle hypometabolic changes in the
posterior cingulate cortex. Detailed neuropsycho-
logical testing revealed deficits in verbal and visual
memory, concentration performance, and verbal
fluency.
We first discussed a frontotemporal dementia-
amyotrophic lateral sclerosis (FTD-ALS) spectrum
disorder. However, candidate gene analyses for the
chromosome 9 open reading frame 72 (C9ORF72)
gene, fused in sarcoma (FUS) gene, and granulin
encoding (GRN) gene yielded negative results. In
the course of the disease, the patient’s husband
reported new behavioral abnormalities. His wife
started to watch children’s programs on TV, and
could not select adequate clothes for herself.
However, in the neurological examination there
were neither relevant signs of frontal disinhibition
nor an obvious progression of motor symptoms,
such as paralysis or dysphagia. In addition to FTD-
ALS, we therefore considered a behavioral variant
of early-onset familial Alzheimer disease, but we did
not find mutations in the APP, PSEN1, and PSEN2
genes. In early 2016, the cognitive impairment
showed moderate progression, however, the motor
signs changed significantly to a poorly Dopa-
responsive, right-lateralized hypokinetic-rigid Par-
kinson syndrome. We obtained follow-up MRI-
and FDG-PET brain imaging, now showing global
atrophy and widespread hypometabolism with
pronounced changes in the posterior cingulate
cortex and in both hippocampi. Follow-up CSF
analysis again showed negative results for amyloid-,
tau, and hyperphosphorlated tau protein. The
patient’s family history still pointed to a fully
penetrant monogenetic neurodegenerative disease.
Because of the changes in motor symptoms over
time, we considered MAPT genotyping, and we
finally detected a heterozygous exon 10 splice side
mutation in the MAPT gene (c.915+16C>T; Ex10
splice + 16) which has been previously described in
families in the USA, UK, and in Australia (Hutton
et al., 1998).
Discussion
This case illustrates various clinical symptoms
of a FTDP-17 patient even during the course
of the disease. For clinicians, it is important to
recognize the value of longitudinal changes in
cognitive, behavioral, and motor symptoms, and to
evaluate rare neurodegenerative diseases in patients
with unusual dementia presentations. Even though
MAPT mutations are named FTDP-17, it is of note
that clinical symptoms vary even in between family
members (Reed et al., 2001; Wszolek et al., 2006).
Although treatment options may be limited, as in
our case, pedigree data and genetic assessments can
be crucial for how to educate patients and their
families.
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